All articles by Miranda Mclaren

Trends in Renal Research: Nephrology’s Shift to Focus and Precision

Nephrology has long been a difficult space for drug development: trials were slow, complex, high cost, and often unrewarding, constrained…
Tell us: Is hospital connectivity keeping up with the demands of modern care in 2026?

For years, healthcare organizations have focused on enabling clinical mobility by giving clinicians access to systems, communication tools, and patient…
Operational Lessons from Global Nephrology Trials

From novel drug targets for chronic kidney disease (CKD)[i] to advances in multifunctional drugs promising better efficacy, recent developments in…
The future of quality in CDMOs: The five-stage journey to an advanced Pharmaceutical Quality System (PQS)

In the first part of our Q&A with Grace Breen, SVP, Quality, Sharp, we explored valuable insights derived from her…
Four ways to build a secure and scalable CGT distribution network

CGTs offer potentially life-changing treatment for a broad spectrum of complex diseases, from genetic conditions to cancers. The pace of…

Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers

Oncology drug development has shifted decisively towards precision immunotherapies, where biomarker-defined patient populations play a pivotal role. Immuno-oncology now represents…
Why Timelines Break Down in Rare Kidney Drug Development

Enrollment challenges continue to be a defining constraint in nephrology research. In a January 2026 snapshot of GlobalData’s clinical trial…
The hidden bottleneck in digital healthcare: Why hospital wireless networks are under pressure in 2026

Healthcare is entering a new era of digital transformation. In the US, competition among leading providers is driving rapid adoption…
CGT’s next obstacle: Securing the leukapheresis supply chain

Clinical trial numbers for CAR-T therapies have risen dramatically in recent years, and as these programmes expand beyond oncology into…
From compliance to culture: Lessons from a quality leader on pharma’s next imperative

We spoke with Grace Breen, Senior Vice President, Quality at Sharp about the role of quality in a CDMO environment,…

Sections